Forbion European Acquisition Borrows up to $990K from Sponsor to Keep Working

Forbion European Acquisition in an 8-K said it issued an unsecured promissory note for $900,000 to its sponsor, which today funded half the amount. The funds will be used for working capital.

The SPAC raised $126.5 million in a December 2021 IPO. Forbion is focused on life sciences companies in Europe. Read more.

Total
0
Shares
Related Posts
Thoma Bravo
Read More

Thoma Bravo Amends $900M IPO Prospectus

Thoma Bravo will seek to partner with a “market-leading, fast-growing software franchise with high-quality and recurring revenue streams in a fragmented market, and that offers attractive organic and inorganic growth opportunities,” the company said in the filing.